Inventor
CHESSARI GIANNI
GB32 patents
⚠️ This page may combine multiple inventors who share the name “CHESSARI GIANNI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
22 patentsUS7754725B2Jul 13, 2010
Dihydroxyphenyl isoindolymethanones
ASTEX THERAPEUTICS LTD22 citations92
US7700625B2Apr 20, 2010
Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
ASTEX THERAPEUTICS LTD25 citations92
US9783538B2Oct 10, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD12 citations91
US9458158B2Oct 4, 2016
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD11 citations84
US10618895B2Apr 14, 2020
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD4 citations83
US9676768B2Jun 13, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD8 citations83
US9617248B2Apr 11, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD10 citations83
US9617283B2Apr 11, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD10 citations83
US10544132B2Jan 28, 2020
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD10 citations82
US10526311B2Jan 7, 2020
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD6 citations82
US9663512B2May 30, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD8 citations82
US11866428B2Jan 9, 2024
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD2 citations72
US11643410B2May 9, 2023
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD1 citations72
US11225476B2Jan 18, 2022
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD3 citations72
US11261171B1Mar 1, 2022
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD2 citations71
US10981898B2Apr 20, 2021
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD4 citations71
US9980973B2May 29, 2018
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD6 citations71
US12202828B2Jan 21, 2025
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD0 citations62
US11236047B2Feb 1, 2022
Combination of isoindolinone derivatives with SGI-110
ASTEX THERAPEUTICS LTD2 citations62
US12071429B2Aug 27, 2024
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD0 citations60
US9914719B2Mar 13, 2018
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
ASTEX THERAPEUTICS LTD0 citations51
US9145354B2Sep 29, 2015
Pharmaceutical compounds
ASTEX THERAPEUTICS LTD0 citations37
CHESSARI GIANNI
4 patentsUS8106057B2Jan 31, 2012
Dihydroxyphenyl isoindolylmethanones
CHESSARI GIANNI19 citations91
US8101648B2Jan 24, 2012
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
CHESSARI GIANNI20 citations91
US8530469B2Sep 10, 2013
Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90
CHESSARI GIANNI11 citations82
US8816087B2Aug 26, 2014
Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
CHESSARI GIANNI2 citations61